{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T06:39:25Z","timestamp":1793255965122,"version":"4.5.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Glucagon-like peptide-1 receptor agonists (GLP-1RAs) are increasing in prevalence as the \u201cgo-to\u201d medication for type 2 diabetes, obesity, and off-label weight loss. The changes associated with the use of these medications can result in an undesirable change in facial structure and skin quality, leading to a more aged appearance in users of these medications. This study aimed to identify whether increased public interest in these GLP-1RA\u2013related face changes, a phenomenon termed \u201cOzempic face,\u201d is associated with increased interest in relevant corrective procedures.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>Google Trends searches for terms related to Ozempic face, and the relevant corrective procedures were statistically analyzed to assess correlative relationships.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>A significant positive trend was present for all Ozempic face\u2013related terms from June 2022 to June 2025, indicating an increase in search for these terms during this time period. There was a significant positive relationship between the increased interest in the facial weight loss\u2013related terms and \u201cfiller\u201d terms, but no significant relationship with surgical procedure terms.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>With the rapid rise in the number of patients on these medications, it is essential for any clinicians who prescribe them or those who follow up with patients who use them to increase their awareness of this phenomenon for appropriate patient counseling and treatment. This study highlights the growing role of facial aesthetic procedures in the care of GLP-1RA users. Our findings underscore the need for greater clinician education and continued research on the most effective and optimal methods for approaching these side effects.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/gox.0000000000007282","type":"journal-article","created":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:00:14Z","timestamp":1763384414000},"page":"e7282","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":8,"title":["Interest in Facial Volume Restorative Procedures With the Rise in \u201cOzempic Face\u201d: A Google Trends Analysis"],"prefix":"10.1097","volume":"13","author":[{"given":"Lana","family":"Mnajjed","sequence":"first","affiliation":[{"name":"Department of Surgery, University of Oklahoma College of Medicine, Tulsa, OK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M.","family":"Mims","sequence":"additional","affiliation":[{"name":"Department of Otolaryngology - Head and Neck Surgery, Division of Facial Plastic Surgery, University of Oklahoma, Oklahoma City, OK."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2025,11]]},"reference":[{"key":"R1-20251117","doi-asserted-by":"crossref","first-page":"e252964","DOI":"10.1001\/jamanetworkopen.2025.2964","article-title":"Spending on glucagon-like peptide-1 receptor agonists among US adults.","volume":"8","author":"Tsipas","year":"2025","journal-title":"JAMA Netw Open"},{"key":"R2-20251117","first-page":"8","article-title":"Poll: roughly 12% of US adults have used a GLP-1 drug, even if unaffordable.","volume":"332","author":"Harris","year":"2024","journal-title":"JAMA"},{"key":"R3-20251117","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2023.2438","article-title":"As Ozempic\u2019s popularity soars, here\u2019s what to know about semaglutide and weight loss.","volume":"329","author":"Suran","year":"2023","journal-title":"JAMA"},{"key":"R4-20251117","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ad.2023.10.008","article-title":"The use of facial fillers in clinical practice: the level of patient satisfaction and an overview of common clinical complications.","volume":"115","author":"Mahmood Faris","year":"2024","journal-title":"Actas Dermosifiliogr"},{"key":"R5-20251117","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1055\/a-2148-6321","article-title":"Implications of Ozempic and other semaglutide medications for facial plastic surgeons.","volume":"39","author":"Humphrey","year":"2023","journal-title":"Facial Plast Surg"},{"key":"R6-20251117","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.bjps.2024.07.051","article-title":"The rise of \u201cOzempic face\u201d: analyzing trends and treatment challenges associated with rapid facial weight loss induced by GLP-1 agonists.","volume":"96","author":"Mansour","year":"2024","journal-title":"J Plast Reconstr Aesthet Surg"},{"key":"R7-20251117","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1055\/s-0032-1305786","article-title":"Injectable fillers for volume replacement in the aging face.","volume":"28","author":"Greco","year":"2012","journal-title":"Facial Plast Surg"},{"key":"R9-20251117","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1007\/s12020-025-04293-w","article-title":"GLP-1RA and the possible skin aging.","volume":"89","author":"Paschou","year":"2025","journal-title":"Endocrine"},{"key":"R10-20251117","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1002\/ohn.1209","article-title":"Radiographic midfacial volume changes in patients on GLP-1 agonists.","volume":"173","author":"Sharma","year":"2025","journal-title":"Otolaryngol Head Neck Surg"},{"key":"R11-20251117","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/PRS.0000000000007518","article-title":"Facial aging: a quantitative analysis of midface volume changes over 11 years.","volume":"147","author":"Boehm","year":"2021","journal-title":"Plast Reconstr Surg"},{"key":"R12-20251117","doi-asserted-by":"crossref","first-page":"ojaf056","DOI":"10.1093\/asjof\/ojaf056","article-title":"\u201cOzempic face\u201d in plastic surgery: a systematic review of the literature on GLP-1 receptor agonist mediated weight loss and analysis of public perceptions.","volume":"7","author":"Daneshgaran","year":"2025","journal-title":"Aesthet Surg J Open Forum"}],"container-title":["Plastic and Reconstructive Surgery - Global Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007282","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T13:00:16Z","timestamp":1763384416000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/GOX.0000000000007282"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":11,"journal-issue":{"issue":"11","published-online":{"date-parts":[[2025]]}},"URL":"https:\/\/doi.org\/10.1097\/gox.0000000000007282","relation":{},"ISSN":["2169-7574"],"issn-type":[{"value":"2169-7574","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,11]]}}}